Agbenyega T, Schuind AE, Adjei S, Antony K, et al. Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial. Lancet Infect Dis 2025;25:861-872.
PMID: 40120597